Immediate Impact
49 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Inflammation and resolution in obesity
2024 Standout
Works of F. Maccari being referenced
Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)
2020
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross‐sectional study
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| F. Maccari | 268 | 198 | 29 | 62 | 43 | 427 | |
| Kourosh Beroukhim | 288 | 240 | 25 | 56 | 31 | 470 | |
| Aida Pašić | 155 | 224 | 9 | 98 | 35 | 373 | |
| G Leigheb | 186 | 147 | 8 | 147 | 42 | 491 | |
| Ethan Levin | 307 | 249 | 4 | 53 | 30 | 443 | |
| M.P. JAMES | 156 | 156 | 6 | 98 | 27 | 492 | |
| Elias Oussedik | 156 | 209 | 14 | 60 | 19 | 428 | |
| Dimitra Koumaki | 128 | 204 | 22 | 66 | 73 | 431 | |
| S N Tham | 146 | 284 | 11 | 89 | 26 | 425 | |
| M. de la Brassinne | 300 | 295 | 15 | 74 | 26 | 496 | |
| A. J. Kanwar | 150 | 209 | 26 | 62 | 33 | 440 |
All Works
Login with ORCID to disown or claim papers
Loading papers...